Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia

OBJECTIVE: To evaluate efficacy and safety of ramelteon (MT(1)/MT(2)-receptor agonist) in subjects with chronic primary insomnia. METHODS: Randomized, multicenter, double-blind, placebo-controlled trial of nightly ramelteon treatment (8 mg or 16 mg) in adults (N=405) with primary chronic insomnia (D...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zammit, Gary, Erman, Milton, Wang-Weigand, Sherry, Sainati, Stephen, Zhang, Jeffrey, Roth, Thomas
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Academy of Sleep Medicine 2007
Schlagworte:
New Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1978328/
https://ncbi.nlm.nih.gov/pubmed/17803013
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge